Skip to content
You are not logged in |Login  
     
Limit search to available items
Record:   Prev Next
Resources
book
BookPrinted Material
Corporate Author United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy.

Title The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992.

Publication Info. Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993.

Item Status

Location Call No. Status OPAC Message Public Note Gift Note
 Moore Stacks  5902    Available  ---
Description iv, 144 pages : illustrations ; 24 cm
Physical Medium 4x6 in.
monochrome
service copy
negative
Bibliography Includes bibliographical references.
Note "Serial no. 102-85."
Reproduction Microfiche. Washington : U.S. G.P.O., 1993. 2 microfiches : negative ; 11 x 15 cm.
Note s 1993 dcu n b
Subject Mifepristone -- Government policy -- United States.
Mifepristone -- Government policy.
United States.
Mifepristone.
Pharmaceutical policy -- United States.
Pharmaceutical policy.
Medicine -- Research -- United States.
Medicine -- Research.
Import quotas -- United States.
Import quotas.
Gpo Item No. 1031-B
Sudoc No. Y 4.SM 1:102-85